Advertisement

Topics

Allergan, Inc. and MAP Pharmaceuticals, Inc. Company Profile

06:14 EST 13th December 2018 | BioPortfolio

Allergan is a multi-specialty health care company established more than 60 years ago with a commitment to uncover the best of science and develop and deliver innovative and meaningful treatments to help people reach their life’s potential. Today, we have approximately 10,800 highly dedicated and talented employees, global marketing and sales capabilities with a presence in more than 100 countries, a rich and ever-evolving portfolio of pharmaceuticals, biologics, medical devices and over-the-counter consumer products, and state-of-the-art resources in R&D, manufacturing and safety surveillance that help millions of patients see more clearly, move more freely and express themselves more fully. From our beginnings as an eye care company to our focus today on several medical specialties, including eye care, neurosciences, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention and urologics, Allergan is proud to celebrate more than 60 years of medical advances and proud to support the patients and physicians who rely on our products and the employees and communities in which we live and work. For more information regarding Allergan, go to: www.allergan.com.


News Articles [590 Associated News Articles listed on BioPortfolio]

Allergan and Editas Medicine to Jointly Develop CRISPR Genome Editing Experimental Medicine EDIT-101

DUBLIN, Ireland and CAMBRIDGE, Mass., Aug. 06, 2018 (GLOBE NEWSWIRE) — Allergan plc (NYSE: AGN), a leading global pharmaceutical company, and Editas Medicine, Inc. (NASDAQ: EDIT), a leading geno...

Allergan, Editas Medicine to jointly develop CRISPR genome editing experimental medicine EDIT─101

Allergan plc, a leading global pharmaceutical company, and Editas Medicine, Inc., a leading genome editing company, announced that Allergan's wholly─owned subsidiary, Allergan Pharmaceuticals

Pfizer creates breaking news with Allergan purchase

US drugs giant Pfizer has sealed a deal to buy Botox-maker Allergan for $160bn (£106bn) in what is the biggest pharmaceuticals deal in history. The takeover could allow Pfizer to escape relatively hi...

The Allergan Model

Allergan is a 'restless company', according to David Pyott, its CEO, and that is what makes it an exciting and dynamic company to work for. Made famous by Botox, Allergan's roots are firmly in ophthal...

Allergan Sues Pfizer Over Opioid Drug

Allergan is suing Pfizer over a morphine-based opioid, Kadian, that Allergan acquired in December 2008.

Allergan acquires neurotoxin specialist Bonti in $195m deal

The Dublin-headquartered multinational Allergan have agreed to acquire the clinical stage biotech Bonti in a deal worth more than $195 million. The deal will see Botox drugmaker Allergan acquire Bonti...

Almirall buys Allergan’s derma portfolio

Almirall is expanding its business by buying Allergan’s dermatology portfolio. The Spanish pharma company will buy five brands from US-based Allergan for up to $650 million in cash. The portfolio ...

Allergan Backs off From $200 Million Plant Expansion in Waco, Texas

Allergan indicated that it “has shifted [its] priority from expanding the Waco site to investing significantly in our existing operations.” However, the company spokesperson said that Allergan “...

Drugs and Medications [336 Associated Drugs and Medications listed on BioPortfolio]

Refresh classic [Allergan, Inc.]

REFRESH Classic

Refresh liquigel [Allergan, Inc.]

REFRESH LIQUIGEL

Refresh celluvisc [Allergan, Inc.]

REFRESH CELLUVISCLubricant Eye Drops

Refresh plus [Allergan, Inc.]

REFRESH PLUSLubricant Eye Drops

Refresh optive sensitive [Allergan, Inc.]

REFRESH OPTIVE™ Sensitive

PubMed Articles [131 Associated PubMed Articles listed on BioPortfolio]

Swimming activity in zebrafish larvae exposed to veterinary antiparasitic pharmaceuticals.

Veterinary antiparasitic pharmaceuticals have been detected in surface waters and several of these pharmaceuticals act on the nervous system on the target organisms implying that neurological effects ...

Chiral pharmaceuticals: Environment sources, potential human health impacts, remediation technologies and future perspective.

Chiral pharmaceuticals (CPs), including non-steroid anti-inflammatory drugs (NSAIDs), β-blockers and some herbicide and pesticides, are widely used in aquaculture, clinical treatment and many other f...

Assessment of 83 pharmaceuticals in WWTP influent and effluent samples by UHPLC-MS/MS: Hourly variation.

The removal efficiency of pharmaceuticals in wastewater treatment plants (WWTPs) is variable and some of these compounds pass these plants almost intact and others presenting a removal efficiency clos...

Effects of pharmaceuticals on microbial communities and activity of soil enzymes in mesocosm-scale constructed wetlands.

Cyperus alternifolius based mesocosm-scale constructed wetland was employed to remove pharmaceuticals. We investigated the microbial community composition using phosphor lipid fatty acids (PFLAs) anal...

Impact of Pharmaceuticals on the Environment: Risk Assessment Using QSAR Modeling Approach.

An extensive use of pharmaceuticals and the widespread practices of their erroneous disposal measures have made these products contaminants of emerging concern (CEC). Especially, active pharmaceutical...

Clinical Trials [252 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1354 Associated Companies listed on BioPortfolio]

Allergan, Inc.

Allergan, Inc. is a multi-specialty health care company established 60 years ago with a commitment to uncover the best of science and develop and deliver innovative and meaningful...

Allergan, Inc. and MAP Pharmaceuticals, Inc.

Allergan is a multi-specialty health care company established more than 60 years ago with a commitment to uncover the best of science and develop and deliver innovative and meanin...

Allergan Inc.

Allergan is a multi-specialty health care company established more than 60 years ago with a commitment to uncover the best of science and develop and deliver innovative and meanin...

Allergan Ligand Retinoid Therapeutics Inc

Allergan, Inc., with headquarters in Irvine, California, is a technology-driven, global health care company that develops and commercializes specialty pharmaceutical products for the eye care, neuromu...

Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc. is focused on developing specialty CNS products designed to address unmet medical needs. The company’s portfolio is well diversified wit...

More Information about "Allergan, Inc. and MAP Pharmaceuticals, Inc." on BioPortfolio

We have published hundreds of Allergan, Inc. and MAP Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Allergan, Inc. and MAP Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Allergan, Inc. and MAP Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Allergan, Inc. and MAP Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Allergan, Inc. and MAP Pharmaceuticals, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...


Corporate Database Quicklinks



Searches Linking to this Company Record